ArticleWorld journal of diabetes2025
Development and validation of a hypoglycemia risk prediction tool for hospitalized patients with type 2 diabetes mellitus treated with insulin.
Article in World journal of diabetes, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundInsulin is the preferred clinical treatment for hospitalized patients with type 2 diabetes mellitus (T2DM) to control blood glucose effectively. Hypoglycemia is one of the most common adverse events. Accurate prediction of the risk of hypoglycemia is critical in reducing hypoglycemic events and related adverse events in hospitalized diabetic patients treated with insulin.
aimTo develop and validate a hypoglycemia risk prediction tool for hospitalized patients with T2DM treated with insulin.
methodsThis retrospective study included 802 hospitalized patients with T2DM in the Department of Endocrinology, the Third Affiliated Hospital of Sun Yat-sen University, between January 2021 and December 2021. The hypoglycemia risk prediction model was developed using logistic regression and nomogram models. The model was validated and calibrated using receiver operating characteristic curves and the Hosmer-Lemeshow goodness of fit test.
resultsThe incidence of hypoglycemia among the enrolled patients was 44.9%. The hypoglycemic risk prediction model included six predictors: Body mass index, duration of diabetes, history of hypoglycemia within 1 year, glomerular filtration rate, blood triglyceride levels, and duration of treatment. The hypoglycemia risk prediction model displayed high discrimination ability (area under the curve = 0.67) and good calibration power (goodness of fit,
conclusionThe hypoglycemia risk prediction model for hospitalized patients with T2DM on insulin therapy displayed high reliability and discrimination ability. The model is a promising tool for clinicians to screen hospitalized patients with T2DM and an elevated risk of hypoglycemia and guide personalized interventions to prevent and treat hypoglycemia.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.